Advances in Biochemical Screening for Phaeochromocytoma using Biogenic Amines |
| |
Authors: | Malcolm J Whiting and Matthew P Doogue |
| |
Institution: | 1. Biochemistry and Pharmacology Laboratory, SA Pathology at Flinders Medical Centre;2. Dept Clinical Pharmacology, Flinders Medical Centre, Bedford Park, SA 5042, Australia |
| |
Abstract: | Biochemical testing for phaeochromocytoma is performed in diagnostic laboratories using a variety of tests with plasma, serum or 24-hour urine collections. These tests include catecholamines and their methylated metabolites - the metanephrines, either individually or in combination with their sulfated metabolites. High-performance liquid chromatography (HPLC) continues to be the dominant analytical method for biogenic amine quantitation. Chromatographic techniques are changing, with improvements in sample preparation procedures, column technology and more specific analyte detection using tandem mass spectrometry. Enrolments in quality assurance programs indicate that there are still many more laboratories in Australasia analysing urinary catecholamines than metanephrines. Nevertheless, clinical evidence and expert opinion favour metanephrines as the analytes with highest sensitivity for the detection of phaeochromocytoma. Practical issues such as better chemical stability and easier specimen collection also favour metanephrines over catecholamines. For these reasons, it is likely that laboratories increasingly will replace urine catecholamine testing with either plasma or urine metanephrines. However in interpreting positive results, the need remains to consider issues such as pre-test probability and use of potentially interfering medications. |
| |
Keywords: | |
|
|